Sherman Asset Management »

Cytokinetics shares owned by Sherman Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Sherman Asset Management from 13F filings

Historical chart of Sherman Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Sherman Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Sherman Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.8k 142 54.96
2025-06-30 $4.7k 142 33.04
2025-03-31 $5.7k 142 40.19
2024-12-31 $6.7k 142 47.04

More positions owned by Sherman Asset Management

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Core S&p Small Cap Etf Etf (IJR)
Technology Select Sector Spdr Fund Etf (XLK)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Oracle Corp Stock (ORCL)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Meta Platforms Inc Cl A Stock (META)
Vanguard Total Bond Market Etf Etf (BND)
First Trust Nasdaq Cybersecurity Etf Etf (CIBR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Vanguard Real Estate Etf Etf (VNQ)
Amazon Stock (AMZN)

View all positions for Sherman Asset Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Tudor Investment Corporation
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group

View all funds holding Cytokinetics